Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference8 articles.
1. Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution;Reig;J Hepatol,2016
2. Early occurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct acting antivirals;Conti;J Hepatol,2016
3. Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with SVR following IFN-free DAA treatment;Kozbial;J Hepatol,2016
4. Direct acting antiviral therapy and tumor recurrence after liver transplant for hepatitis C-associated hepatocellular carcinoma;Yang;J Hepatol,2016
5. Lack of evidence of an effect of Direct Acting Antivirals on the recurrence of hepatocellular carcinoma;Pol;J Hepatol,2016
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01
2. Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals;European Journal of Immunology;2023-08-06
3. Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus;Gastroenterology & Endoscopy;2023-01
4. The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment;Internal Medicine;2022-09-15
5. Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus;Journal of Viral Hepatitis;2022-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3